RankAlpha logo
Back to Rankings

TVTX

Travere TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
TVTX vs peer average
55/100
TVTX vs. peer average (B vs. B)
Grade spread
A 2 · B 4 · C 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

TARS is the first available peer comparator.

Tarsus is a same-cap biotech/commercial launch comparator rather than a direct kidney-disease peer; useful for event-driven commercial-execution sentiment, but weak for indication-specific valuation read-through.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerTARSTarsus
TVTX
Travere Therapeutics
TARS
Tarsus
Grade
B
C
Momentum
91
23
Value
41
41
Sentiment
50
96
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs TARS

TVTX / TARS
Grade Position
In line
TVTX vs. peer average (B vs. B)
55/100
Momentum
91
TVTX
Value
41
TVTX
Sentiment
50
TARS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TVTX
1
TARS
TARS
C
60/100
+1
2
CNTA
CNTA
B
80/100
Even
3
EWTX
Edgewise Therapeutics Inc Common
B
80/100
Even
4
AMRX
Amneal Pharmaceuticals Inc Class A Common
B
80/100
Even
5
TXG
10x Genomics Inc Class A Common
C
60/100
+1
TARS is the first peer returned for this comparison set.